Assessment of Risk Factor for the Development of Diabetes & Other Central Nervous System Abnormalities in LCH
Development of a Single Chain Monoclonal Antibody to CD1a for Immunoimaging and Treatment of Patients with Langerhans Cell Histiocytosis
Cell-Associated and Soluble Macrophage Mannose Receptor: A Potential New Marker for Langerhans Cell Histiocytosis
Investigation of Possible Associations of Histocompatibility and/or Tumor Necrosis Factor Types with Susceptibility to LCH or Particular Clinical Manifestations of this Disease
Isolation, Identification, and Studies on the Biology of a Transmissible Agent Involved in the Causation of Langerhans Cell Histiocytosis: Implications for Future Treatment Strategies for Disseminated LCH
